Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
US6218383A · kind A · utility
15Cited by
9References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 7, 1998 |
| Grant date | Apr 17, 2001 |
| Priority date | — |
| Expiry date | Aug 7, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition incorporates a pharmaceutically effective amount of at least two components, one of those components being a nicotinic compound capable of interacting with nicotinic cholinergic receptors (e.g., a nicotinic agonist, such as E-metanicotine) and one of those components being an acetylcholinesterase inhibitor (e.g., tacrine). The pharmaceutical composition is useful for treating CNS disorders, such as Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.